Shailender Bhatia, MD

Dr. Shailender Bhatia M.D.

Shailender Bhatia, MD

Clinical Research Division, Fred Hutch

Fax: 206.606.1314
Mail Stop: CE2-102

Dr. Shailender Bhatia aims to improve outcomes for people with kidney cancers and skin cancers, especially melanoma and Merkel cell carcinoma. He leads clinical trials of new immunotherapies and targeted, less-toxic therapies for patients with these diseases.

Other Appointments & Affiliations

Professor, Division of Hematology and Oncology
University of Washington

Research Interests

Dr. Bhatia’s research efforts are mostly focused on clinical trials that aim at improving outcomes in skin cancers (especially Melanoma and Merkel cell carcinoma). He is especially interested in those novel therapeutic approaches that stimulate the immune system against cancer and those that target therapy to the tumors in order to spare unnecessary toxicity.

Find an Active Clinical Trial Led by Dr. Bhatia

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210